Skip to main content

REV 20 mg (Revlimid 20 mg)

Generic Name: lenalidomide

Pill with imprint REV 20 mg is Blue / Green, Capsule-shape and has been identified as Revlimid 20 mg. It is supplied by Celgene Corporation.

Revlimid is used in the treatment of multiple myeloma; myelodysplastic diseases; follicular lymphoma; mantle cell lymphoma; lymphoma and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Revlimid 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for REV 20 mg

Revlimid 20 mg REV 20 mg


Generic Name
REV 20 mg
20 mg
Blue / Green
Prescription only
Drug Class
Miscellaneous antineoplastics, Other immunosuppressants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Celgene Corporation
National Drug Code (NDC)
Inactive Ingredients
lactose anhydrous, microcrystalline cellulose, croscarmellose sodium, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.